Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Fischer

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Plos One|December 24, 2014
The novel 10-item asthma prediction tool: external validation in the German MAS birth cohortLinus B Grabenhenrich, Andreas Reich, Felix Fischer, et al.
Journal of Clinical Epidemiology|November 8, 2024
The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional studyAnnika Döhmen, Alexander Obbarius, Milan Kock, et al.
Clinical Kidney Journal|June 3, 2026
Hemodiafiltration beyond the CONVINCE trialGiovanni F M Strippoli, Krister Cromm, Vasileios C Pezoulas, et al.
Journal of Clinical Epidemiology|March 19, 2026
Standardizing physical function across assessment types: Three versions of the Physical Performance Test were linked to the PROMIS Physical Function metric in diverse populationsAudrey Yuki Brinker, Frank Buttgereit, Andreas Heißel, et al.
Trials|September 29, 2021
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trialMaria Margarete Karsten, Friedrich Kühn, Therese Pross, et al.
Nature Communications|October 27, 2024
Spin-orbit proximity in MoS<sub>2</sub>/bilayer graphene heterostructuresMichele Masseroni, Mario Gull, Archisman Panigrahi, et al.
Journal of Patient-Reported Outcomes|July 31, 2025
Measurement properties of the PROMIS-29 profile v2.1 in a Norwegian rehabilitation contextStein Arne Rimehaug, Rikke Helene Moe, Hanne Dagfinrud, et al.
Plos One|June 1, 2026
Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCEAniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, et al.
Brain, Behavior, and Immunity|December 5, 2021
Immune signature of multiple sclerosis-associated depressionJelena Brasanac, Caren Ramien, Stefanie Gamradt, et al.
Journal of Affective Disorders|May 30, 2026
Comparison of the accuracy of latent factor and sum scoring of the hospital anxiety and depression scale to screen for major depression: An individual participant data meta-analysisJieting Zhang, Felix Fischer, Carl Falk, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Plos One|December 24, 2014
The novel 10-item asthma prediction tool: external validation in the German MAS birth cohortLinus B Grabenhenrich, Andreas Reich, Felix Fischer, et al.
Journal of Clinical Epidemiology|November 8, 2024
The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional studyAnnika Döhmen, Alexander Obbarius, Milan Kock, et al.
Clinical Kidney Journal|June 3, 2026
Hemodiafiltration beyond the CONVINCE trialGiovanni F M Strippoli, Krister Cromm, Vasileios C Pezoulas, et al.
Journal of Clinical Epidemiology|March 19, 2026
Standardizing physical function across assessment types: Three versions of the Physical Performance Test were linked to the PROMIS Physical Function metric in diverse populationsAudrey Yuki Brinker, Frank Buttgereit, Andreas Heißel, et al.
Trials|September 29, 2021
PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trialMaria Margarete Karsten, Friedrich Kühn, Therese Pross, et al.
Nature Communications|October 27, 2024
Spin-orbit proximity in MoS<sub>2</sub>/bilayer graphene heterostructuresMichele Masseroni, Mario Gull, Archisman Panigrahi, et al.
Journal of Patient-Reported Outcomes|July 31, 2025
Measurement properties of the PROMIS-29 profile v2.1 in a Norwegian rehabilitation contextStein Arne Rimehaug, Rikke Helene Moe, Hanne Dagfinrud, et al.
Plos One|June 1, 2026
Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCEAniek E M Schouten, Geert W J Frederix, Martijn M Stuiver, et al.
Brain, Behavior, and Immunity|December 5, 2021
Immune signature of multiple sclerosis-associated depressionJelena Brasanac, Caren Ramien, Stefanie Gamradt, et al.
Journal of Affective Disorders|May 30, 2026
Comparison of the accuracy of latent factor and sum scoring of the hospital anxiety and depression scale to screen for major depression: An individual participant data meta-analysisJieting Zhang, Felix Fischer, Carl Falk, et al.
Pageof 13